These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8769113)

  • 41. Manipulation of the fate of long chain polyunsaturated fatty acids in cultured cells.
    Galli C; Risé P; Marangoni F; Petroni A; Visioli F
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):23-6. PubMed ID: 9250604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The biochemical basis of the biosynthesis of cholesterol and fatty acids].
    Lynen F
    Wien Klin Wochenschr; 1966 Jul; 78(27):489-97. PubMed ID: 4296920
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition by plant growth retardants of cholesterol biosynthesis in slices of rat liver and hepatoma.
    Paleg L; Sabine JR
    Aust J Biol Sci; 1971 Dec; 24(6):1125-30. PubMed ID: 4359980
    [No Abstract]   [Full Text] [Related]  

  • 44. Physiological aspects and mechanism of action of mevalonate 5-diphosphate decarboxylase.
    Jabalquinto AM; Alvear M; Cardemil E
    Comp Biochem Physiol B; 1988; 90(4):671-7. PubMed ID: 3073910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.
    Shama Bhat C; Ramasarma T
    Biochem J; 1979 Jul; 181(1):143-51. PubMed ID: 226078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multisite inhibition by phenylacetate of PC-3 cell growth.
    Bahl JJ; De Armond RL; Bressler R
    Anticancer Drugs; 2004 Jun; 15(5):513-23. PubMed ID: 15166627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of cholesterol synthesis by lovastatin tested on six human cell types in vitro.
    Sviridov DD; Safonova IG; Pavlov MY; Kosykh VA; Podrez EA; Antonov AS; Fuki IV; Repin VS
    Lipids; 1990 Mar; 25(3):177-9. PubMed ID: 2159099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of hepatic cholesterol biosynthesis by chloroquine.
    Beynen AC; van der Molen AJ; Geelen MJ
    Lipids; 1981 Jun; 16(6):472-4. PubMed ID: 7266270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening of microbial secondary metabolites inhibiting cholesterol biosynthesis with the use of hepatoblastoma G2].
    Trenin AS; Terekhova LP; Tolstykh IV; Zenkova VA; Fedorova GB; Katrukha GS
    Antibiot Khimioter; 2003; 48(1):3-8. PubMed ID: 12741315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The phosphorylation mechanism of mevalonate diphosphate decarboxylase: a QM/MM study.
    McClory J; Hui C; Zhang J; Huang M
    Org Biomol Chem; 2020 Jan; 18(3):518-529. PubMed ID: 31854421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship of cholesterol biosynthesis to cancer.
    Siperstein MD
    Trans Am Clin Climatol Assoc; 1972; 83():156-64. PubMed ID: 4340647
    [No Abstract]   [Full Text] [Related]  

  • 52. Steroidomimetic aminomethyl spiroacetals as novel inhibitors of the enzyme Δ8,7-sterol isomerase in cholesterol biosynthesis.
    Krojer M; Müller C; Bracher F
    Arch Pharm (Weinheim); 2014 Feb; 347(2):108-22. PubMed ID: 24493593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of fatty acid synthesis in marine fungus-like protists.
    Xie Y; Wang G
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8363-75. PubMed ID: 26286514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatty acid modulation of HepG2 cell cholesterol biosynthesis and esterification.
    Schäfer HF; Kattermann R
    Clin Biochem; 1992 Oct; 25(5):325-30. PubMed ID: 1337020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of cholesterol biosynthesis which act at or beyond the mevalonic acid stage.
    Holmes WL; Ditullio NW
    Am J Clin Nutr; 1962 Apr; 10():310-22. PubMed ID: 13908532
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression.
    Fernández C; Martín M; Gómez-Coronado D; Lasunción MA
    J Lipid Res; 2005 May; 46(5):920-9. PubMed ID: 15687348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cholesterine synthesis as an object of the action of drugs. (Review of the literature)].
    Cherkes AI; Klebanov BM
    Farmakol Toksikol; 1966; 29(6):751-7. PubMed ID: 6000378
    [No Abstract]   [Full Text] [Related]  

  • 58. Simultaneous inhibition of alternative pathways of cholesterol biosynthesis by two related hypocholesteremic agents.
    Black ML; Rodney G; Capps DB
    Biochem Pharmacol; 1968 Sep; 17(9):1803-14. PubMed ID: 5688268
    [No Abstract]   [Full Text] [Related]  

  • 59. Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway.
    Benson HE; Watterson S; Sharman JL; Mpamhanga CP; Parton A; Southan C; Harmar AJ; Ghazal P
    Br J Pharmacol; 2017 Dec; 174(23):4362-4382. PubMed ID: 28910500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholesterol biosynthesis and homeostasis in regulation of the cell cycle.
    Singh P; Saxena R; Srinivas G; Pande G; Chattopadhyay A
    PLoS One; 2013; 8(3):e58833. PubMed ID: 23554937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.